Fundamental Analysis
41 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +752.3% | +224.8% | 1 / 3 | -5.3% | -5.83 pp | +0.60 pp | +4.8% | 1.77 | 8.37 | 292 | −5,3% | 2,0 | +752,3% | 8.37 | 11.33 | −26,2% |
| Pts | 12 | 12 | 4 | 0 | 0 | 8 | 0 | -4 | 12 | |||||||
Valuation annotation:Price: 13.000 (close price on 2026-10-15)EPS (TTM): 1.554
Financial charts
1.Revenue & growth
VND bn292Q2/26
1.Revenue & growth
VND bn292Q2/26
2.Profit & growth
VND bn1,97Q2/26
3.Profit mix (Penman)
VND bn20,1Q2/26
4.Margins & cost structure
%8.6%Q2/26
5.Returns & cash cycle
% · days5.3%Q2/26
6.Earnings quality & cash
VND bn7,90Q2/26
7.Asset structure
VND bn1.347Q2/26
8.Funding & debt health
VND bn · times1.347Q2/26
9.Revenue backlog
VND bn122Q2/26
10.Valuation
times · %8,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %209Q2/26
Adjusted EPS growth, latest quarter
752%
Average adjusted EPS growth, 3 quarters
225%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26